Reflections from a Changing Lipedema Landscape

Thoughts on surgery, GLP-1 medications, body image, nutrition and why I think it is important to stay curious when the answers are still evolving.

There has been an unusual amount happening in the lipedema field recently. New research is being published, surgical treatment is receiving greater scientific attention, GLP-1 receptor agonists have become increasingly visible in patient discussions, and questions surrounding weight, metabolism, inflammation and long-term disease management appear to be moving closer to the centre of the conversation. I have tried to follow these developments closely, both because of my scientific background and because I live with lipedema myself. What I have noticed, however, is that the more I read, the less interested I become in arriving quickly at definitive positions. Some of the questions being discussed are important precisely because we do not yet have satisfactory answers to them, and I increasingly think there is value in allowing ourselves to remain uncertain for a while.

I therefore want to be very clear about what this article is and what it is not. This is not a scientific review, a clinical recommendation or an attempt to establish what other women with lipedema should believe or do. It is a reflection on several questions that have occupied my mind recently, written from the intersection of my background in nutrition and food science, my interest in lipedema research, and my own experience of living with the condition. These are my thoughts today, and I deliberately use the word today. I may think differently after reading new research, hearing experiences that challenge my assumptions, or simply living through another six months in my own body. I do not consider that inconsistency. To me, it is an important part of remaining intellectually curious. If our understanding develops while our opinions remain completely unchanged, there is probably reason to ask whether we are genuinely evaluating new information or merely defending positions we have already taken.

I would love to hear your current perspectives in the comments. Let’s grow together.

When the language around treatment becomes stronger than the evidence feels

One example that has made me think about this recently is the discussion surrounding liposuction. Following the publication of new clinical evidence in The Lancet, I saw commentary raising the possibility of considering liposuction as a potentially curative treatment for lipedema. My immediate reaction was discomfort, although I have tried not to turn that reaction into a conclusion. I have undergone liposuction myself and experienced substantial benefits from surgery, so my hesitation does not come from opposition to surgical treatment. On the contrary, I know personally how meaningful symptom improvement can be. What makes me hesitate is the conceptual leap from demonstrating substantial therapeutic benefit to describing an intervention as a cure.

From my current perspective, there may be a blind spot in focusing too quickly on that question. Lipedema is still a condition for which many fundamental biological questions remain unresolved. We continue to investigate the roles of adipose tissue biology, connective tissue, microvascular function, lymphatic changes, inflammation, pain mechanisms and hormonal influences, and we still do not have a complete explanation for why the disease develops or why its phenotype and progression vary considerably between individuals. Removing affected adipose tissue may produce profound and durable clinical improvements without necessarily demonstrating that the underlying susceptibility or biology responsible for the condition has been eliminated. Those are not necessarily the same claim, and I think the distinction deserves careful attention.

My own experience also influences how I interpret this discussion. Surgery significantly improved aspects of my lipedema, yet I do not experience myself as someone whose relationship with the condition simply ended after liposuction. My body continues to respond to hormonal changes, fluid shifts, stress and other physiological circumstances. This does not prove anything scientifically; an individual experience cannot establish the biological nature of a disease or determine whether a treatment should be classified as curative. Nevertheless, lived experience can identify questions that deserve investigation, and mine makes me cautious about language suggesting that removing diseased tissue necessarily resolves the entire condition.

Have you experienced the same? Let me know in the comments.

At the same time, I do not think the discussion about cure should be dismissed merely because I am uncomfortable with it. Scientific progress often requires someone to ask a question that initially seems too ambitious, provocative or premature. Perhaps future evidence will support a definition of surgical treatment that is much stronger than the terminology we use today. Perhaps it will show the opposite. The important point, at least for me, is that I do not currently feel a need to decide. I would rather examine the argument, understand what would actually have to be demonstrated for the word curative to be appropriate, and remain open to changing my position as the evidence develops.

Want to go deeper into the science of lipedema?

Become a LipedemaScience member and get full access to all articles, research deep dives, practical insights and member-only content. Your membership also supports my work in finding, reading and translating the latest lipedema research into information that is easier to understand and use.

Join now and get a special discount on your first year of membership.

Why I am thinking so much about GLP-1 medications

A second subject that has occupied considerably more of my attention recently is the increasing use and discussion of GLP-1-based medications. I have mixed feelings about this development, and those feelings are probably more complicated because they involve both scientific questions and deeply personal ones. I can see why these medications have generated enormous interest. There are people for whom pharmacological treatment of obesity has produced changes that years of conventional weight-management attempts did not achieve, and I do not think those experiences should be minimised. If someone experiences better metabolic health, greater mobility, improved quality of life or relief from a lifelong struggle with appetite and weight, it would be inappropriate for me to dismiss that because I personally have reservations about aspects of how these medications are being discussed.

What concerns me more is the speed with which GLP-1 medications can sometimes move from being one therapeutic option to appearing almost like the obvious answer whenever body weight becomes difficult to manage. I have noticed this increasingly in conversations surrounding lipedema, and I am not yet convinced that we have found the right balance. I am interested in questions about long-term use, adverse effects, nutritional adequacy, preservation of muscle mass, cost, weight trajectories after treatment changes, and the extent to which commercial interests influence the research landscape and public conversation. None of these considerations means that the medications are inherently problematic, nor does pharmaceutical funding automatically invalidate research. They simply mean that I think a powerful medical intervention deserves the same critical evaluation we should apply to any other treatment.

I’d be so happy if you shared this with a friend with lipedema who is also curious about this topic.

Nutrition is particularly important to me in this context. When appetite and total food intake decrease substantially, the nutritional composition of what remains becomes increasingly consequential. Adequate protein, micronutrients, essential fatty acids and overall dietary quality do not become less important because someone is losing weight; arguably, they require greater attention. Muscle mass, physical function, bone health, energy availability and the ability to maintain an active life also matter independently of the number on a scale. This is one reason I become uncomfortable when successful treatment is discussed primarily in terms of becoming smaller. For some individuals, weight reduction can be medically important, but a smaller body is not automatically synonymous with a healthier body.

I am particularly interested in whether there is a larger role for high-quality nutritional support in women with lipedema who want or need to manage their weight. I would like us to become better at helping people understand energy balance, satiety, protein, food quality, meal composition, muscle preservation and sustainable behavioural change without turning nutrition into another restrictive ideology. That does not mean believing that lifestyle can replace medication for everyone, nor does it mean assuming that people who require medical treatment simply failed to eat correctly. Those would be equally simplistic conclusions. What interests me is the substantial territory between those extremes: identifying who may benefit substantially from medication, who may be able to achieve their goals without it, and how nutritional care should support both groups.

When physiology becomes psychologically difficult

My interest in this subject is also influenced by what is happening in my own life. I am preparing for another egg retrieval, and previous fertility treatments have taught me something about how quickly my rational understanding of physiology can become disconnected from how I feel about my body. Hormonal treatment can produce considerable fluid retention for me. My body can feel softer, fuller and unfamiliar, and clothes that fitted comfortably only a short time earlier may suddenly become tight. Intellectually, I understand that rapid changes of this kind can reflect fluid rather than an equivalent accumulation of adipose tissue. Emotionally, however, the distinction can become much more difficult when I am standing in front of a mirror and do not recognise the body I expected to see.

If you enjoy reading my reflections and exploring the science of lipedema with me, I’d love to have you here. Subscribe to LipedemaScience and I’ll send new articles straight to your inbox.

I find this psychologically challenging precisely because I generally consider myself to have a relatively balanced relationship with health, nutrition and my body. Most of the time, I can look at the uneven areas on the back of my thighs and recognise that they have very little relevance to the quality of my life. I have a body that allows me to work, run, travel, build things and participate in the life I want. I have a partner who loves me, and my value is obviously not determined by whether the surface of my thighs is completely smooth. I am not working in an industry in which my livelihood depends on maintaining a particular physical appearance. From a rational perspective, the conclusion seems straightforward: who actually cares about a few irregularities on the back of my legs?

Yet rational knowledge does not make us immune to insecurity. There are periods when I become much more critical of my body, and hormonal changes seem particularly capable of shifting me into that state. The feeling of being swollen or “fluffy” can become mentally translated into a feeling that I have gained fat, lost control or somehow failed, even when I know that interpretation is physiologically questionable. That experience has made me think more carefully about the psychological dimension of weight-management discussions. It is very easy to talk about kilograms, appetite and body composition as abstract variables, but these changes occur inside people who have histories, expectations, vulnerabilities and relationships with their bodies. A treatment can therefore affect much more than body weight alone.

This time, I am trying to prepare for that psychological response before the hormonal changes occur. I know that I may reach a point during or after treatment when my clothes fit differently and my body feels unfamiliar. Rather than waiting until that moment to convince myself that nothing has gone wrong, I am trying to establish that perspective beforehand. My body may retain fluid. Its appearance may temporarily change. I may dislike that change. None of those things necessarily means that I have gained a meaningful amount of body fat or that I need to respond by restricting food, increasing exercise compulsively or trying to regain control as quickly as possible.

Are you a LipedemaScience fan? I’d love it if you shared this publication with a friend or someone you know with lipedema. It really helps LipedemaScience reach more people who might find this information valuable.

Why I do not want weight management to become food restriction

This is also where my personal philosophy around food becomes relevant. I care deeply about nutrition, but I care equally about preserving a healthy relationship with eating. Food is not simply a mechanism for delivering nutrients. It is also pleasure, culture, social connection, curiosity and one of the ways we share our lives with other people. I do not want to build a version of health in which I achieve a particular body composition at the cost of becoming afraid of dinners, holidays, restaurants or foods that exist primarily because they are enjoyable.

In my own life, I often think loosely in terms of an 80/20 approach. This is not a nutritional prescription or a scientifically derived ratio; it is simply a mental framework that helps me maintain perspective. I want the majority of my diet to consist of nutritious, high-quality foods that support my health, while deliberately leaving enough flexibility for the parts of eating that have nothing to do with optimisation. I want to be able to travel and experience local food, eat dessert, have dinner with friends and occasionally choose something because I want it rather than because it represents the theoretically optimal nutritional decision. For me, sustainability requires that flexibility.

Perhaps this explains part of my hesitation when appetite suppression itself is presented as an uncomplicated benefit. I understand that for someone who has experienced persistent hunger or food preoccupation, reducing appetite can feel profoundly liberating. I also understand that my own relationship with appetite cannot be generalised to someone living with obesity or metabolic disease. Nevertheless, I personally value appetite, enjoyment of food and the social experience of eating, and I would not want to lose those things unnecessarily. This does not make GLP-1 treatment wrong; it simply means that the balance between benefit and cost will not be identical for every individual.

The space between two extremes

The more I think about these questions, the more interested I become in what exists between the opposing positions that dominate many health conversations. We should be able to acknowledge that body weight can influence health without reducing lipedema to a consequence of excess weight. We should be able to recognise the importance of nutrition without suggesting that women caused their disease through dietary choices. We should be able to investigate lifestyle interventions without implying that people who need medication have somehow failed. Equally, we should be able to recognise the remarkable potential of modern pharmacological treatments without assuming that medication is necessarily the preferred solution for every person who would like to lose weight.

The same principle applies to surgery. It should be possible to recognise liposuction as a potentially transformative treatment without immediately needing to decide whether it constitutes a cure. Perhaps the terminology will eventually change as our understanding improves. For now, I am more interested in what surgery actually changes, what remains after treatment, which outcomes persist over decades, whether disease processes continue in remaining tissue, and how patients themselves experience their bodies many years after surgery. Those questions may ultimately tell us far more than debating terminology before the biology is sufficiently understood.

Have a question you’d like to ask me personally? Feel free to send me a message. I’d love to hear from you.

There is something uncomfortable about remaining in this middle ground because certainty is psychologically attractive. It is easier to divide treatments into good and bad, natural and pharmaceutical, conservative and radical, or curative and merely symptomatic. The problem is that biology rarely respects the categories we create for it. A treatment can be highly effective and still have limitations. A medication can be life-changing for one person and inappropriate for another. Nutrition can profoundly influence health without curing a disease. Surgery can remove pathological tissue and dramatically improve symptoms while leaving unanswered questions about underlying disease mechanisms. None of these statements requires the other side of the argument to be wrong.

I want to be allowed to change my mind

Perhaps the most important reflection I have arrived at is that I want to become increasingly comfortable saying, “This is what I think today.” I do not want LipedemaScience to become a place where I establish a position and then spend years selecting information that confirms it. If I am genuinely interested in science, I need to remain willing to encounter evidence that is inconvenient to what I currently believe. The same applies to listening to other people’s experiences. Patient experiences cannot replace controlled research, but they can reveal questions, outcomes and priorities that researchers may not otherwise recognise.

I also think we should extend that freedom to one another. Someone may be enthusiastic about GLP-1 treatment today and decide after personal experience that it is not right for them. Someone who is currently deeply sceptical may eventually use one of these medications and find it transformative. A woman may initially view liposuction primarily as symptom management and later come to believe that “curative” is an appropriate description of her own outcome. Another may have surgery and reach precisely the opposite conclusion. Changing an opinion after acquiring new information or experience should not automatically be interpreted as hypocrisy or inconsistency. Sometimes it is simply evidence that a person has continued thinking.

Why I Started LipedemaScience

That is why I am deliberately not trying to conclude this article with an answer. I do not currently know exactly where I will ultimately land on some of these questions. I have reservations about describing liposuction as a cure, but I want to understand the argument rather than dismiss it. I see enormous potential in GLP-1-based treatment, while simultaneously questioning whether the enthusiasm surrounding it may sometimes move faster than the nuanced conversation we need about nutrition, muscle, long-term health, body image and individual suitability. I strongly believe in the importance of nutrition and lifestyle, while also recognising that they are not substitutes for every medical treatment and should never become another way of assigning responsibility or blame to people living with a chronic condition.

Become a member and be part of a growing community exploring the science behind lipedema together. Today, people with lipedema from more than 60 countries are reading LipedemaScience, learning, asking questions and staying curious together. I’d love to have you here too.

These are therefore reflections rather than recommendations, and I would genuinely like to hear experiences that challenge as well as support them. I am interested in hearing from women who have used GLP-1 medications and those who deliberately decided not to, from people whose understanding of surgery changed after undergoing it, and from women who recognise the strange psychological experience of watching hormones and fluid temporarily change a body they thought they knew. Most of all, I am interested in whether other people also find themselves changing their minds as they learn more.

Perhaps that willingness to change is not something we need to apologise for. In a field where so much remains uncertain, staying curious may be one of the most scientifically responsible positions we can take.